Postoperative Steroid Use in Adolescent Idiopathic Scoliosis and Neuromuscular Scoliosis Patients
Key facts
- Who runs it
- Children's Hospital Los Angeles
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 100 people, planned
- Started
- 1 Nov 2025
- Expected to end
- 31 Dec 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Dexamethasone
- Record updated
- 5 March 2025
Who can take part
- Age
- 9 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Participants must meet all of the inclusion criteria to participate in this study:
- Patients aged 9-18 years who are scheduled to undergo posterior spinal fusion to treat AIS or NMS
Who cannot take part
- Prior instrumentation or spine surgery
- Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements
- Conditions associated with increased wound healing issues such as spina bifida
- Allergies to the steroids and/or their ingredients
- Outside the ages of 9-18
- Patients will be excluded if any of the following criteria are met at baseline:
- Non AIS or NMS patients
- Not undergoing PSF
- Inability or unwillingness of individual or legal guardian/representative to give written informed consent
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 9 and 18 years old?
Where in United States
- Children's Hospital Los AngelesLos Angeles, United StatesContact: Tiffany PhanNot yet recruiting
About the trial
What the trial wants to find out
The goal of this randomized clinical trial is to compare the immediate use of steroids after surgery for accelerated discharge in adolescent idiopathic scoliosis and neuromuscular scoliosis after a posterior spinal fusion.
Read full original descriptionShow less
The main question it aims to answer are:
* What are the effects of using steroids immediately after surgery in decreasing opioid use and helping early mobilization(movement)? * Does post-operative steroid use affect the incidence of wound complications and are there any long-term impacts on scar formation?
Participants will:
* Fill out a Patient-Reported Outcomes Measurement Information System (PROMIS) survey specifically for pain interference and physical activity observing health related quality of life at enrollment, 3 months, 1 year, and 2 years * Have clinical photos of their incision at 3 months, 1 year, and 2 years
* Their photos will be assessed using the stony book scar evaluation scale * For treatment of their scoliosis, patients will undergo a posterior spinal fusion (PSF) per standard of care, however whether the participant receives or does not receive steroids is what the investigators are trying to understand. * Researchers will compare no immediate postoperative steroid (NS) to the group with immediate postoperative steroid (WS) group to see if there are changes in opioid use, wound complications, scar formation, and facilitation in early mobilization.
The 2 groups in the trial
- No Steroid (NS)No study treatment, for comparison
No Dexamethasone (NS)
- With Steroid (WS)Treatment being tested
With Dexamethasone (WS)
Treatment: Dexamethasone
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized Trial of Postoperative Steroid Use Following Posterior Spinal Fusion in 100-subject Adolescent Idiopathic Scoliosis (AIS) and Neuromuscular Scoliosis (NMS)
- Criteria questions
- Built from NCT06023043, who can take part
- Record updated
- 5 March 2025